Petros Pharmaceuticals's total assets for Q4 2025 were $5.16B, an increase of 84087.25% from the previous quarter. PTPI total liabilities were $2.29B for the fiscal quarter, a 82808.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.